Description

LuciPoma 2mg Capsule (Pomalidomide) Uses, Side Effects, Dosage & Price in Pakistan

LuciPoma 2mg Capsule (Pomalidomide) is an oral prescription anticancer medicine containing pomalidomide. Pomalidomide belongs to a class of medicines known as immunomodulatory drugs (IMiDs) and is structurally related to thalidomide.

Pomalidomide is primarily used as part of treatment for certain adults with multiple myeloma, a cancer of plasma cells. Depending on the approved indication in a particular country, pomalidomide may also be used for certain patients with Kaposi sarcoma.

LuciPoma 2mg is a capsule strength and should not be interpreted as the standard starting dose for every patient. Pomalidomide treatment is individualized according to the cancer being treated, treatment combination, blood counts, side effects, kidney and liver function, and other medicines being used.

Patients searching for LuciPoma 2mg Capsule in Pakistan can check current product information, price, and availability through Impo Medic. Because pomalidomide can cause serious fetal harm, blood clots, and severe changes in blood-cell counts, treatment must be prescribed and monitored by an experienced healthcare professional.

LuciPoma 2mg Capsule (Pomalidomide) Uses

Pomalidomide has an established role in the treatment of multiple myeloma.

In U.S. prescribing information, pomalidomide in combination with dexamethasone is indicated for adults with multiple myeloma who have received at least two previous therapies, including lenalidomide and a proteasome inhibitor, and whose disease progressed during or shortly after their last treatment.

Treatment indications and combinations can differ between countries and regulatory approvals.

Pomalidomide also has a U.S. indication for certain adults with Kaposi sarcoma, including AIDS-related Kaposi sarcoma after failure of highly active antiretroviral therapy and Kaposi sarcoma in HIV-negative patients.

The appropriate indication for LuciPoma should always be determined by an oncologist or hematologist.

How Does LuciPoma 2mg Capsule Work?

Pomalidomide has several actions that contribute to its anticancer effects.

It has immunomodulatory, anti-proliferative, and anti-angiogenic properties. It can influence immune-system activity and interfere with processes that allow certain cancer cells to survive and multiply.

In multiple myeloma, pomalidomide helps suppress the growth of abnormal plasma cells and is commonly incorporated into combination treatment rather than being considered a simple stand-alone medicine.

The exact response varies between patients, so blood tests and clinical assessments are required throughout treatment.

LuciPoma 2mg Capsule Dosage

The dose of pomalidomide must be determined by an oncology specialist.

For multiple myeloma, established prescribing information generally recommends pomalidomide 4mg orally once daily on Days 1 through 21 of repeated 28-day treatment cycles, usually in combination with dexamethasone.

This means that LuciPoma 2mg Capsule is not automatically the standard starting dose simply because the product contains 2mg.

A 2mg strength may be used when a lower dose is clinically required, including some dose-modification situations.

Dose interruption or reduction may be required because of:

• Neutropenia
• Thrombocytopenia
• Other serious adverse effects
• Severe kidney impairment requiring dialysis
• Liver impairment
• Important drug interactions

Never increase, decrease, stop, or restart pomalidomide without instructions from the treating specialist.

How to Take LuciPoma 2mg Capsule

Take LuciPoma exactly according to the treatment schedule prescribed by your healthcare professional.

Pomalidomide capsules are generally taken:

• Once daily on the prescribed treatment days
• At approximately the same time each day
• With or without food
• Swallowed whole with water

Do not break, chew, or open the capsule.

If powder from a damaged capsule comes into contact with the skin, wash the affected area immediately with soap and water.

Because pomalidomide can cause severe fetal harm, pregnant women should not handle opened, broken, or damaged capsules.

What If a Dose Is Missed?

Do not automatically take an extra LuciPoma capsule to compensate for a missed dose.

Pomalidomide has specific missed-dose instructions, and taking doses too close together may increase the risk of toxicity.

Follow the instructions provided with the medicine or contact your oncology team if you are unsure what to do after a missed dose.

Never double the next dose unless specifically instructed by the treating healthcare professional.

Common Side Effects of LuciPoma 2mg Capsule

Pomalidomide can cause significant adverse effects, and regular monitoring is an important part of treatment.

Common adverse effects reported with pomalidomide treatment can include:

• Fatigue
• Weakness
• Constipation
• Nausea
• Diarrhea
• Fever
• Shortness of breath
• Back pain
• Upper respiratory infections
• Reduced white blood-cell counts
• Anemia
• Reduced platelet counts

Not every patient develops these problems, and their severity can vary considerably.

Contact your healthcare team if symptoms become persistent or severe.

Low Blood Counts and Infection Risk

Hematologic toxicity is one of the most important risks associated with pomalidomide.

Pomalidomide can cause:

• Neutropenia
• Anemia
• Thrombocytopenia

Neutropenia means the number of infection-fighting neutrophils becomes too low, increasing susceptibility to serious infections.

Thrombocytopenia increases the risk of unusual bleeding or bruising.

Complete blood counts are therefore required regularly during treatment. Your specialist may temporarily stop treatment or reduce the dose if blood counts fall below acceptable levels.

Seek medical attention promptly for fever, chills, signs of infection, unusual bleeding, or unexplained bruising.

Pregnancy and Severe Birth-Defect Warning

Pomalidomide can cause severe birth defects or embryo-fetal death and must not be used during pregnancy.

It is related to thalidomide, a medicine known to cause severe congenital abnormalities.

Females who can become pregnant require strict pregnancy-prevention measures before, during, and after treatment according to the applicable pomalidomide pregnancy-prevention program.

Pregnancy testing is required according to prescribing protocols.

Male patients must also follow required contraceptive precautions because pomalidomide can be present in semen.

Patients should not donate blood during treatment and for the required period after treatment.

If pregnancy occurs or is suspected during pomalidomide treatment, contact the treating healthcare professional immediately.

Blood Clot Risk

Pomalidomide carries an important warning for venous and arterial thromboembolism.

Serious events can include:

• Deep-vein thrombosis (DVT)
• Pulmonary embolism (PE)
• Heart attack
• Stroke

Patients with multiple myeloma receiving pomalidomide may be prescribed thromboprophylaxis depending on their individual clotting risk.

Seek urgent medical attention for symptoms such as sudden chest pain, unexplained shortness of breath, swelling or pain in one leg, sudden weakness, difficulty speaking, or other possible symptoms of a blood clot or stroke.

Liver Problems

Serious liver injury, including liver failure, has been reported with pomalidomide.

Doctors may monitor liver-function tests before and during treatment.

Contact your healthcare professional if you develop symptoms that could suggest liver problems, such as:

• Yellowing of the skin or eyes
• Dark urine
• Persistent nausea
• Unusual tiredness
• Right-sided upper abdominal discomfort

Treatment may need to be interrupted if significant liver abnormalities develop.

Severe Skin and Allergic Reactions

Serious skin reactions have been reported with pomalidomide, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.

Severe allergic reactions, including angioedema and anaphylaxis, can also occur.

Seek urgent medical attention if you develop a widespread or blistering rash, skin peeling, swelling of the face or throat, difficulty breathing, or another severe allergic reaction.

Kidney and Liver Impairment

Kidney and liver function can affect pomalidomide treatment.

Patients with severe renal impairment requiring dialysis may require a different dose. On dialysis days, prescribing information may require pomalidomide to be administered after hemodialysis.

Dose reductions may also be necessary in patients with hepatic impairment.

This is another reason why LuciPoma 2mg Capsule should never be selected solely according to product strength. The treating specialist must determine the correct dose for each patient.

Drug Interactions

Tell your oncologist about every medicine and supplement you use.

Strong CYP1A2 inhibitors can increase pomalidomide exposure and may require avoidance or dose adjustment.

Medicines that may be clinically relevant should be reviewed by the treating healthcare professional before treatment begins.

Smoking can also affect pomalidomide exposure, so patients should tell their healthcare professional if they smoke tobacco.

Do not start or stop prescription medicines, non-prescription products, herbal remedies, or supplements during cancer treatment without discussing them with your medical team.

Breastfeeding

Breastfeeding is generally not recommended during pomalidomide treatment because of the potential for serious adverse reactions in a nursing infant.

Patients who are breastfeeding or planning to breastfeed should discuss this with their healthcare professional before treatment.

Storage and Safe Handling

Store LuciPoma 2mg Capsule according to the instructions printed on the original product packaging.

Keep the medicine:

• In its original packaging
• Protected from inappropriate heat or moisture
• Away from children and pets
• Secure from anyone for whom it was not prescribed

Do not share pomalidomide with another person, even if that person has the same diagnosis.

Do not use capsules that are damaged or expired.

Because LuciPoma is a specific branded product, follow the storage information supplied with the actual pack rather than assuming that another pomalidomide brand has identical storage requirements.

LuciPoma 2mg Capsule Price in Pakistan

The LuciPoma 2mg Capsule price in Pakistan can vary according to product availability, pack size, supplier, import conditions, and market changes.

Specialist oncology medicines may experience stock and price fluctuations, so patients should confirm current information before purchasing.

You can check the latest LuciPoma 2mg Capsule price and availability in Pakistan through Impo Medic.

When obtaining oncology medicines, it is important to verify the correct product, strength, batch information, expiry date, packaging condition, and prescribed quantity.

How to Buy LuciPoma 2mg Capsule in Pakistan

Patients looking to buy LuciPoma 2mg Capsule in Pakistan can check current stock and product information through Impo Medic.

Before purchasing, verify:

• LuciPoma product name
• Pomalidomide as the active ingredient
• 2mg capsule strength
• Original packaging
• Batch details
• Expiry date
• Prescribed quantity

Pomalidomide is a specialist prescription anticancer medicine and should not be purchased for self-treatment.

A 2mg capsule should only be used when that strength forms part of the treatment plan prescribed by the patient’s oncology team.

Why Choose Impo Medic?

Impo Medic provides medicine information and availability support for patients and caregivers searching for specialist medicines in Pakistan.

For oncology medicines such as LuciPoma, correct product identification and strength are particularly important. Pomalidomide is available in different strengths, and the correct strength depends on the patient’s prescribed treatment plan rather than simply choosing the lowest or highest available dose.

Customers can check LuciPoma 2mg Capsule price and availability in Pakistan through Impo Medic, while all decisions about indication, treatment cycle, dose reduction, laboratory monitoring, and combination therapy should remain with a qualified oncology specialist.

FAQs About LuciPoma 2mg Capsule (Pomalidomide)

What is LuciPoma 2mg Capsule used for?

Pomalidomide is primarily used as part of treatment for certain adults with multiple myeloma. It also has an approved indication for certain patients with Kaposi sarcoma in some jurisdictions.

Is LuciPoma 2mg the normal starting dose for multiple myeloma?

Not generally. Established U.S. prescribing information recommends 4mg once daily on Days 1–21 of repeated 28-day cycles for multiple myeloma, usually with dexamethasone. A 2mg strength may be used when dose reduction or another individualized regimen is required.

Is LuciPoma chemotherapy?

Pomalidomide is an immunomodulatory anticancer medicine rather than a traditional cytotoxic chemotherapy drug. It affects cancer-cell growth and immune-system activity.

Can LuciPoma cause low blood counts?

Yes. Pomalidomide can cause neutropenia, anemia, and thrombocytopenia. Regular complete blood-count monitoring is therefore an important part of treatment.

Can LuciPoma cause blood clots?

Yes. Pomalidomide is associated with venous and arterial blood clots, including DVT and pulmonary embolism. Doctors assess each patient’s risk and may prescribe preventive treatment when appropriate.

Can LuciPoma be used during pregnancy?

No. Pomalidomide can cause severe birth defects or embryo-fetal death and is contraindicated during pregnancy. Strict pregnancy-prevention requirements apply.

Can I open a LuciPoma capsule?

No. The capsule should be swallowed whole. Do not break, chew, or open it.

Can LuciPoma be taken with food?

Pomalidomide can generally be taken with or without food. Follow the exact administration instructions provided by your healthcare professional and product labeling.

Where can I check LuciPoma 2mg price in Pakistan?

You can check the current LuciPoma 2mg Capsule price and availability in Pakistan through Impo Medic. Because specialist medicine pricing can change, confirm the latest information at the time of purchase.